l-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: Results of the GRASPALL 2005-01 randomized trial

British Journal of Haematology

Volumn 153, Issue 1, 2011, Pages 58-65

  Halfon Domenech, Carine ^a   Thomas, Xavier ^b   Chabaud, Sylvie ^c   Baruchel, Andre ^d   Gueyffier, François ^e   Mazingue, Françoise ^f   Auvrignon, Anne ^g   Corm, Selim ^f   Dombret, Herve ^d   Chevallier, Patrice ^h   Galambrun, Claire ⁱ   Huguet, Françoise ^j   Legrand, Faezeh ^k   Mechinaud, Françoise ^h   Vey, Norbert ^l   Philip, Irène ^c   Liens, David ^m   Godfrin, Yann ^m   Rigal, Dominique ⁿ   Bertrand, Yves ^a  

^a UNIVERSITÉ LYON 1   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c CENTRE LÉON BÉRARD   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g ARMAND TROUSSEAU HOSPITAL   (France)

^h HÔTEL DIEU   (France)

ⁱ TIMONE HOSPITAL   (France)

^j TOULOUSE UNIVERSITY HOSPITAL   (France)

^k UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^l INSTITUT PAOLI CALMETTES   (France)

^m ERYTECH PHARMA   (France)

ⁿ ETABLISSEMENT FRANÇAIS DU SANG   (France)

more..

Author keywords

Childhood leukaemia; Erythrocytes; Leukaemia; New drugs for leukaemia

Indexed keywords

ASPARAGINASE; ASPARAGINE; GRASPA; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE PANCREATITIS; ADOLESCENT; ADULT; ANAPHYLACTIC SHOCK; ARTICLE; BLOOD CLOTTING DISORDER; CELL ENCAPSULATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG WITHDRAWAL; ERYTHROCYTE; ESCHERICHIA COLI; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOALBUMINEMIA; HYPOPROTEINEMIA; LEUKEMIA RELAPSE; LIVER TOXICITY; LUNG ASPERGILLOSIS; MULTICENTER STUDY; PANCREAS DISEASE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN DEPLETION; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; THROMBOSIS; TREATMENT DURATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; ASPARAGINASE; BIOREACTORS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ERYTHROCYTES; HUMANS; INFANT; MALE; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; YOUNG ADULT;

EID: 79952607367     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08588.x     Document Type: Article

References (15)

1. Avramis, V.I., Sencer, S., Periclou, A.P., Sather, H., Bostrom, B.C. & Cohen, L.J. (2002) A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study. Blood, 99, 1986-1994.
2. Distasio, J.A., Salazar, A.M., Nadji, M. & Durden, D.L. (1982) Glutaminase-free asparaginase from vibrio succinogenes: an antilymphoma enzyme lacking hepatoxicity. International Journal of Cancer, 30, 343-347.
3. Domenech, C., Mercier, M., Plouvier, E., Puraveau, M., Bordigoni, P., Michel, G., Benoit, Y., Leverger, G., Baruchel, A. & Bertrand, Y. (2008) First isolated extramedullary relapse in children with B-cell precursor acute lymphoblastic leukaemia: results of the Cooprall-97 study. European Journal of Cancer, 44, 2461-2469.
4. Duval, M., Suciu, S., Ferster, A., Rialland, X., Nelken, B. & Lutz, P. (2002) Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial. Blood, 99, 2734-2739.
5. Kelo, E., Noronkoski, T., Stoineva, I.B., Petkov, D.D. & Mononen, I. (2002) Beta-aspartylpeptides as substrates of l-asparaginase s from Escherichia coli and Erwinia chrysanthemi. FEBS Letters, 528, 130-132.
6. Kravtzoff, R., Colombat, P.H., Desbois, I., Linassier, C., Muh, J.P., Philip, T., Blay, J.Y., Gardenbas, M., Poumier-Gaschard, P., Lamagnere, J.P., Chassaigne, M. & Ropars, C. (1996a) Tolerance evaluation of l-asparaginase loaded in red blood cells. European Journal of Clinical Pharmacology, 51, 221-225.
7. Kravtzoff, R., Desbois, I., Lamagnere, J.P., Muh, J.P., Valat, C., Chassaigne, M., Colombat, P. & Ropars, C. (1996b) Improved pharmacodynamics of l-asparaginase -loaded in human red blood cells. European Journal of Clinical Pharmacology, 49, 465-470.
8. Le, Q.H., Thomas, X., Ecochard, R., Iwaz, J., Lhéritier, V., Michallet, M. & Fiere, D. (2007) Proportion of long-term event-free survivors and lifetime of adult patients not cured after a standard acute lymphoblastic leukemia therapeutic program: adult acute lymphoblastic leukemia-94 trial. Cancer, 109, 2058-2067.
9. Oettgen, H.F., Stephenson, P.A., Schwartz, M.K., Leeper, R.D., Tallai, L., Tan, C., Clarkson, B.D., Golbey, R.B., Krakoff, I.H., Karnofsky, D.A., Murphy, M.L. & Burchenal, J.H. (1970) Toxicity of E. colil-asparaginase in man. Cancer, 25, 253-278.
10. Panosyan, E.H., Grigoryan, R.S., Avramis, I.A., Seibel, N.L., Gaynon, P.S., Siegel, S.E., Fingert, H.J. & Avramis, V.I. (2004) Deamination of glutamine is a prerequisite for optimal asparagine deamination by asparaginases in vivo (CCG-1961). Anticancer Research, 24, 1121-1125.
11. Pui, C.H. (1995) Childhood leukemia. The New England Journal of Medicine, 332, 1618-1630.
12. Pui, C.H. (2003) Current Clinical Oncology: Treatment of Acute Leukemia: New directions for Clinical Research, pp. 183-219. Humana Press Inc, Totowa, NJ.
13. Pui, C.H., Robison, L. & Look, A.T. (2008) Acute lymphoblastic leukemia. Lancet, 371, 1030-1043.
14. Raff, T., Gökbuget, N., Lüschen, S., Reutzel, R., Ritgen, M., Irmer, S., Böttcher, S., Horst, H.A., Kneba, M., Hoelzer, D. & Brüggemann, M. (2007) GMALL Study Group. Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06/99 and 07/03 trials. Blood, 109, 910-915.
15. Woo, M.H., Hak, L.J., Storm, M.C., Evans, W.E., Sandlund, J.T., Rivera, G.K., Wang, B., Pui, C.H. & Relling, M.V. (1998) Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia. Leukemia, 12, 1527-1533.